Company profile

Eledon Pharmaceuticals, Inc. Insider Trading

ELDN

Every SEC Form 4 insider trading filing for Eledon Pharmaceuticals, Inc. (ELDN) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001404281
Filings
41
Insiders
22
Last filing
2026-07-31

Activity summary

Mixed insider activity over the last 30 days: 2 purchases and 2 sales (4 transactions total).

Quarterly balance

Buy and sell value by quarter, Q2 23 to Q3 26. Eledon Pharmaceuticals, Inc. insiders are net buyers across the period shown.

Q2 23Q4 23Q2 24Q4 24Q1 25Q1 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $17.3M.

90 day insight

Over the last 90 days, Eledon Pharmaceuticals, Inc. insiders bought $0 (2 transactions) and sold $902K (2 transactions).

  • Most active insider: Gros David-Alexandre C with 2 transactions totaling $658K.
  • Largest single sale: $658K by Gros David-Alexandre C on Jul 31, 2026.

Activity is mixed — buys and sales are roughly balanced.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 31, 2026Perrin StevenELDN
Tax Withholding
72,138$3.38$244K
Jul 31, 2026Perrin StevenELDN
Award
152,353
Jul 31, 2026Gros David-Alexandre CELDN
Tax Withholding
194,791$3.38$658K
Jul 31, 2026Gros David-Alexandre CELDN
Award
354,454
Jan 10, 2026Katkin KeithELDN
Option Exercise
8,575

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=ELDN" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Bvf Partners L P/il10% owner3 filings+$17.3M
Gros David-Alexandre CChief Executive Officer1 filing$658K
Perrin StevenPresident1 filing$244K

Institutional Ownership

Top 13F-HR holders of Eledon Pharmaceuticals, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$32.2M
QoQ change
-74.4%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$12.0M
3.1M shares
#2
BlackRock, Inc.
CIK 0002012383
$6.4M
1.6M shares
#3
State Street Corp
CIK 0000093751
$6.4M
1.6M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →